| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Katz Michael David M.D. serves as a Director at HNVR. Across recent SEC filings that breaks down to 3 buys and 1 sell. Those positions are worth an estimated $4.2M at current prices.
Historically, Katz Michael David M.D.'s trades have earned a below-average insider score of 41/100 across 4 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -5.8%.
The biggest single holding is HNVR (~$4.2M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 65 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | HNVR Hanover Bancorp, Inc. /md | Director | Sell | 5,000 | $25.53 | $127,650.00 | -3.2% | -17.5% | -7.6% | |
| Aug 12, 2022 | HNVR Hanover Bancorp, Inc. /md | Director | Buy | 65 | $20.06 | $1,304.13 | +260.0% | -4.4% | -10.2% | |
| May 11, 2022 | HNVR Hanover Bancorp, Inc. /md | Director | Buy | 5,000 | $21.00 | $105,000.00 | +3.6% | +0.4% | -9.9% |